beta cell regeneration stimulators (Stanford University School of Medicine)

N/A

Report date: 2025/03/14 16:26:48
NME

Base Information

Drug Namebeta cell regeneration stimulators (Stanford University School of Medicine)
Drug Alias Nameadenosine kinase inhibitors (Stanford University School of Medicine)sk-08096
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine kinase inhibitors
TargetsAdenosine kinase
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStanford University School of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesStanford University School of Medicine
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A